Introduction
β-Catenin plays important roles in the cadherin-mediated cellcell adhesion system and in Wnt signal transduction, binding to T cell factor (Tcf) in the nucleus and regulating transcription of genes related to the development and differentiation of cells (1) . Down-regulation of β-catenin requires binding of APC protein and phosphorylation by the serine-threonine glycogen synthase kinase-3β (GSK-3β) (2, 3) . Mutations in the GSK-3β phosphorylation consensus motif of β-catenin genes, as well as APC mutations, cause stabilization of β-catenin in the cytoplasm and induce constitutive transcriptional activation with Tcf-4, a member of the Tcf family of DNA-binding proteins (4) . Recently, mutations of the β-catenin gene have been found in 50% of human colon tumors possessing an intact APC gene (5) , suggesting that activation of the β-catenin/ Tcf-mediated transcription pathway caused by mutations of Abbreviations: AOM, azoxymethane; DMH, 1,2-dimethylhydrazine; GSK-3β, glycogen synthase kinase-3β; RFLP, restriction enzyme fragment length polymorphism; SSCP, single strand conformation polymorphism; Tcf, T cell factor.
the APC or β-catenin genes is very important for colon neoplasia.
In rat colon carcinogenesis induced by azoxymethane (AOM), K-ras gene mutations are as frequent as in human colorectal tumors (6) , but Apc gene alterations are only rarely observed (7) . Recently, we have reported frequent mutation and altered cellular localization of β-catenin in rat colon adenocarcinomas induced by AOM (8) . In the mouse case, Maltzman et al. have reported that expression of Apc protein appears to be reduced in AOM-induced tumors (9) , so it is expected that Apc may be a mutational target of the carcinogen. In the present study, to clarify the mechanisms of AOMinduced colon carcinogenesis in the mouse, we investigated alteration of β-catenin in AOM-induced mouse colon tumors in terms of mutations and immunostaining pattern.
Materials and methods

Tumor samples
Male ICR mice (Charles River Japan, Atsugi, Japan) at 6 weeks of age were treated with AOM at a dose of 10 mg/kg body wt, once a week for 6 weeks, as previously reported (10) . Tumors obtained at week 30 were fixed in 10% formalin, embedded in paraffin, sectioned and stained with hematoxylin and eosin for histological examination. Ten adenocarcinomas from five randomly selected AOM-treated mice were subjected to mutation analysis of the β-catenin and K-ras genes and immunohistochemical staining of β-catenin.
PCR-single strand conformation polymorphism (SSCP) analysis
DNA was extracted from paraffin sections using DEXPAT™ (TaKaRa Shuzo Co. Ltd, Shiga, Japan). Tumor tissues were scraped off from paraffin sections entirely, i.e. not from particular parts of tumor tissues, using needles under a stereomicroscope to avoid contamination with normal tissue. PCR primers for detection of β-catenin mutations were designed to amplify exon 3 of the β-catenin gene containing the consensus sequence for GSK-3β phosphorylation (8): 5Ј-primer, GCTGACCTGATGGAGTTGGA; 3Ј-primer, GCTACTTG-CTCTTGCGTGAA. The length of the PCR product with these primers is 227 bp. PCR primers for detection of K-ras mutations were designed to amplify exon 1 of the gene (11) with a PCR product length of 123 bp: 5Ј-primer, GCCTGCTGAAAATGACTGAG; 3Ј-primer, CCTCTATCGTAGGGTCG-TAC. The primers were synthesized with a 394 DNA/RNA synthesizer (Applied Biosystems, Foster City, CA) and purified with an OPC cartridge (Applied Biosystems). PCR for non-radioisotopic SSCP was performed in 50 µl of reaction mixture consisting of 0.5 µM of each primer, 1ϫ PCR buffer (Perkin Elmer, Applied Biosystems Division, Foster City, CA), 200 µM each dNTP, 2.5 U AmpliTaq Gold™ (Perkin Elmer) and 0.05-0.5 µg of template DNA. The mixture was heated to 94°C for 9 min and subjected to 50 cycles of denaturation (94°C, 1 min), annealing (55°C, 2 min) and extension (72°C, 3 min) using a Perkin-Elmer Cetus thermal cycler. The PCR products were purified and concentrated to 20 µl using Microcon 100 (Amicon Inc., Beverley, MA), before SSCP analysis and direct sequencing. Ten volumes of 95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol were added to 0.5 µl of purified PCR products, heated to 90°C for 3 min and applied to 10% polyacrylamide gels containing 5% glycerol. Electrophoresis was carried out at 300 V for 2 h at 20°C and the gels were soaked in 10% trichloroacetic acid and in 50% methanol for 10 min each. DNA bands were detected by silver staining using 2D Silver Staining Solution II (Daiichi Chemical Co., Tokyo, Japan).
Restriction fragment length polymorphism (RFLP) assay for PCR products of β-catenin
To detect β-catenin mutations at codons 32, 33 and 34, PCR products were treated with the restriction enzymes HinfI and EcoRI and electrophoresed on 5 and 3% agarose gels, respectively. Recognition sequences of these enzymes are GANTC for HinfI and GAATTC for EcoRI. The PCR product of 227 bp Fig. 1 . PCR-SSCP analysis of the β-catenin gene in AOM-induced mouse colon tumors. PCR products were electrophoresed in 10% polyacrylamide gels containing 5% glycerol at 20°C. Lanes N1 and N2, normal colon mucosa samples; lanes T1-T10, colon tumors. Tumor-specific bands are indicated by arrows. Fig. 2 . RFLP analysis of the β-catenin gene in AOM-induced mouse colon tumors. PCR products were treated with HinfI and electrophoresed on 5% agarose gels. Lane M, DNA size markers (φX174/HaeIII digest); lanes N1 and N2, normal colon mucosa samples; lanes T1-T10, colon tumors. Tumor-specific bands are indicated by arrows.
is digested by HinfI to 82, 7 and 138 bp in the case of the wild-type, to 89 and 138 bp with mutations at the first or second bases of codons 32 or 33 and to 82 and 145 bp with mutations at the second or third bases of codons 34 or 35. EcoRI does not cut the wild-type PCR product, but generates 81 and 146 bp fragments if there is a G→A mutation at the first base of codon 32.
Direct DNA sequencing With 1 µl of the purified PCR products and 5ЈDyeAmidite-667-labeled 5Ј or 3Ј PCR primers (synthesized by Pharmacia Biotech, Tokyo, Japan), cycle sequencing reactions were carried out using a Thermo Sequenase™ fluorescent labeled primer cycle sequencing kit (Amersham) and the sequences were determined with an ALF express™ DNA sequencer (Pharmacia Biotech).
Immunohistochemical staining
Immunohistochemical analyses were carried out by the avidin-biotin complex immunoperoxidase technique as previously described (8) . As the primary antibody, monoclonal mouse anti-β-catenin (Transduction Laboratories, Lexington, KY) was used at 100 times dilution. As the secondary antibody, biotinylated anti-mouse IgG (HϩL) raised in a horse, affinity purified and absorbed with rat serum (Vector Laboratories Inc., Burlingame, CA) was employed at 200 times dilution. Staining was performed using avidinbiotin reagents (Vectastain ABC reagents; Vector Laboratories Inc.), 3,3Ј-diaminobenzidine and hydrogen peroxide. The sections were counterstained with methyl green. As a negative control, duplicate sections were immunostained without exposure to the primary antibody.
Results
By PCR-SSCP and RFLP analyses, mutations in the GSK-3β phosphorylation consensus motif of the β-catenin gene were detected in all 10 AOM-induced colon tumors of male ICR mice (Figures 1 and 2) . Table I lists the mutated sequences determined by direct sequencing of PCR products. Of the 10 mutations detected, four were located at the second base of codon 34, two at the second base of codon 33, two at the second base of codon 41, one at the second base of codon 37 and one at the first base of codon 33. Except for the last, all were G:C→A:T transitions (Figure 3) .
Using the same DNA samples employed for mutation analysis of the β-catenin gene, K-ras gene mutations were analyzed by PCR-SSCP. A mutation in exon 1 was detected in one of the 10 tumors (data not shown) and determined to 1118 be a G→A transition at the second base of codon 12 by direct sequencing (Table I) .
In normal colon mucosa, immunostaining revealed β-catenin to be mainly localized at the cell membranes of the surface epithelial cells, with a possible cytoplasmic location, and β-catenin immunoreactivity in crypt cells was relatively low ( Figure 4A ). In contrast, cytoplasmic and nuclear immunostaining or loss of cell membrane staining was observed in all of the tumors examined ( Figure 4C and D) . The cytoplasmic staining in tumor cells was homogeneous, while the nuclear staining was homogeneous or heterogeneous, the latter being either scattered or focal. Patterns of nuclear staining of β-catenin were homogeneous in four tumors and heterogeneous in five tumors, three of scattered type and two focal (Table I) . In one tumor, nuclear staining of β-catenin was very weak, although cytoplasmic staining was observed.
Discussion
In the present study of AOM-induced colon tumors in mice, β-catenin gene mutations were detected in all tumor samples tested. Alteration of the subcellular localization of β-catenin was also observed. These results indicate that AOM-induced colons carcinogenesis is similarly mediated by β-catenin mutations in both rats and mice, although there are differences in immunostaining patterns and the mutation spectrum between the two species.
The β-catenin gene is frequently mutated at codons 33, 41 and 45 of the GSK-3β phosphorylation motif in human colon cancers without APC mutations (6) . Besides mutations at codons 33 and 41 of the β-catenin gene, mutations at codons 32 and 34 are frequent in rat colon tumors induced by AOM (8) . The second G of the CTGGA sequence is commonly mutated to A in codons 32 and 34 of the rat β-catenin gene and this site is considered to be a mutational hot-spot with AOM (8) . In the present study, the mouse β-catenin gene was found to be mutated at codons 34, 33, 41 and 37, nine of 10 mutations being G:C→A:T transitions, but not at codon 32. Thus the hot-spot in codon 34 may be present in common, further supporting our hypothesis that the second G of the CTGGA sequence is of particular importance.
In rat colon carcinogenesis induced by AOM or 1,2-dimethylhydrazine (DMH), K-ras gene mutations are as frequent as in human colorectal tumors (6). However, K-ras mutations were not detected in DMH-induced colon tumors in SWR mice (12) and, in the present study, only one of 10 colon tumors induced by AOM in ICR mice had a K-ras gene mutation. These findings suggest that activation of the K-ras gene is not essential for colon tumor development in mice.
In Min/ϩ and Apc ∆716 knockout mice, animal models for familial adenomatous polyposis, nuclear translocation of β-catenin in intestinal adenomas has been reported (13) . The tumors in these model mice have been shown to lack a wildtype allele of the Apc gene (14, 15) and the loss of intact Apc protein may cause stabilization of β-catenin (2). On the other hand, as mentioned in the Introduction, Maltzman et al. reported reduced expression of Apc protein also in AOMinduced tumors (9) , suggesting that Apc is a mutational target of the carcinogen. The discrepancy with the findings of the present study, taking into account data for rats, might not be related to species differences. Immunostaining of the samples used in the present study for Apc protein using a C-terminal anti-APC antibody showed reduced expression in nine of 10 β-Catenin mutations in mouse colon tumors tumors (data not shown). Therefore, it is possible that mutant β-catenin causes a reduction in Apc expression. Alternatively, immunoreactivity could be different between free Apc and the protein bound to exon 3-mutated β-catenin.
In our previous study in rats, nuclear staining of β-catenin in most tumors showed a scattered heterogeneous pattern (8) and the homogeneous nuclear staining observed in the present study seems to be distinctive for mouse colon tumors. It is known that β-catenin is tyrosine-phosphorylated in response to transformation via activated Ras and Src or stimulation by EGF and HGF (1). Modifications like tyrosine phosphorylation and/or the presence of other factors such as Tcf may be involved in determining the location of β-catenin.
In conclusion, β-catenin gene mutations may be common main events in AOM-induced colon carcinogenesis in both rats and mice, even if other background factors vary with the species. These animal models are thus useful for investigation of the role of β-catenin mutations in colon neoplasia. 
